Literature DB >> 3007579

Relationship of superoxide production to cytoplasmic free calcium in human monocytes.

S P Scully, G B Segel, M A Lichtman.   

Abstract

Calcium has been proposed as an intracellular second messenger for activation of secretion, phagocytosis, and the oxidative burst of neutrophils. We have examined the role of calcium in human monocyte activation. Concanavalin A (Con A)-stimulated monocytes displayed an increment in cytoplasmic ionized calcium at 31 +/- 6 s and the onset of superoxide production at 61 +/- 9 s. The increase in cytoplasmic calcium invariably preceded the onset of superoxide production. If the external calcium concentration was reduced to less than 28 nM by the addition of 10 mM EGTA, superoxide production was not diminished at 5 min; however, superoxide production decreased thereafter. The Con A-evoked increment in cytoplasmic ionized calcium was blunted upon the addition of EGTA and decreased further with time. Both the production of superoxide and the Con A-evoked increment in cytoplasmic ionized calcium displayed a 50% inhibition after 15 min of calcium depletion and were completely inhibited after 60 min. Total cell calcium fell from 0.7 to 0.5 fmol/cell, and the basal level of ionized calcium fell from 83 to 30 nM after 60 min. Histidine, a strong chelator of divalent cations other than calcium and magnesium, had no effect on monocyte superoxide production or on ionized calcium concentrations, indicating that EGTA inhibition was due to cell calcium depletion. In calcium-depleted cells, Con A did not evoke superoxide production until calcium was restored to the incubation medium. The restoration of calcium to Con A-treated, calcium-depleted monocytes permitted a rapid rise in the cytoplasmic ionized calcium, and the production of superoxide within 9 s. These data suggest that an increase in ionized cytoplasmic calcium is necessary for the activation of monocyte superoxide production by Con A. The rise in ionized calcium in response to Con A results, in part, from an internal redistribution of calcium, which is sufficient to permit superoxide generation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3007579      PMCID: PMC424494          DOI: 10.1172/JCI112440

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  The roles of extracellular and intracellular calcium in lysosomal enzyme release and superoxide anion generation by human neutrophils.

Authors:  J E Smolen; H M Korchak; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1981-11-05

2.  Is cytosolic ionized calcium regulating neutrophil activation?

Authors:  T Pozzan; D P Lew; C B Wollheim; R Y Tsien
Journal:  Science       Date:  1983-09-30       Impact factor: 47.728

3.  Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor.

Authors:  J R White; P H Naccache; T F Molski; P Borgeat; R I Sha'afi
Journal:  Biochem Biophys Res Commun       Date:  1983-05-31       Impact factor: 3.575

4.  Calcium transport and calcium-ATPase activity in human lymphocyte plasma membrane vesicles.

Authors:  A H Lichtman; G B Segel; M A Lichtman
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

5.  The role of calcium in the initiation of superoxide release from alveolar macrophages.

Authors:  A Holian; R P Daniele
Journal:  J Cell Physiol       Date:  1982-10       Impact factor: 6.384

6.  Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Authors:  R Y Tsien; T Pozzan; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

7.  Calcium transport in inside-out membrane vesicles prepared from rabbit neutrophils.

Authors:  M Volpi; P H Naccache; R I Sha'afi
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

8.  The mechanism of macrophage activation induced by Ca2+ ionophore.

Authors:  K Onozaki; T Takenawa; Y Homma; T Hashimoto
Journal:  Cell Immunol       Date:  1983-02-01       Impact factor: 4.868

9.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides.

Authors:  M J Berridge; R M Dawson; C P Downes; J P Heslop; R F Irvine
Journal:  Biochem J       Date:  1983-05-15       Impact factor: 3.857

10.  Plasma membrane vesicles prepared from unadhered monocytes: characterization of calcium transport and the calcium ATPase.

Authors:  S P Scully; G B Segel; M A Lichtman
Journal:  Cell Calcium       Date:  1982-12       Impact factor: 6.817

View more
  5 in total

1.  Microchip electrophoresis with laser-induced fluorescence detection for the determination of the ratio of nitric oxide to superoxide production in macrophages during inflammation.

Authors:  Giuseppe Caruso; Claudia G Fresta; Joseph M Siegel; Manjula B Wijesinghe; Susan M Lunte
Journal:  Anal Bioanal Chem       Date:  2017-05-29       Impact factor: 4.142

2.  Mycobacterial growth and sensitivity to H2O2 killing in human monocytes in vitro.

Authors:  P Laochumroonvorapong; S Paul; C Manca; V H Freedman; G Kaplan
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  The type of interaction with Fc gamma R in human monocytes determines the efficiency of the generation of oxidative burst.

Authors:  J A Casado; J Merino; J Cid; M L Subira; A Sanchez-Ibarrola
Journal:  Immunology       Date:  1994-09       Impact factor: 7.397

4.  Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells.

Authors:  Gema Martin-Manso; Susana Galli; Lisa A Ridnour; Maria Tsokos; David A Wink; David D Roberts
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

5.  Targeting therapy for homocysteic acid in the blood represents a potential recovery treatment for cognition in Alzheimer's disease patients.

Authors:  Tohru Hasegawa; Wataru Ukai
Journal:  Aging (Albany NY)       Date:  2016-09-14       Impact factor: 5.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.